39 Development and Validation of a Questionnaire to Assess Motivation and Satisfaction in Mastectomy Patients With or Without Reconstruction

Publication
Article
Miami Breast Cancer Conference® Abstracts Supplement42nd Annual Miami Breast Cancer Conference® - Abstracts
Volume 39
Issue 4
Pages: 78-79

39 Development and Validation of a Questionnaire to Assess Motivation and Satisfaction in Mastectomy Patients With or Without Reconstruction

39 Development and Validation of a Questionnaire to Assess Motivation and Satisfaction in Mastectomy Patients With or Without Reconstruction

Background/Significance

Postmastectomy breast reconstruction provides several options, including immediate or delayed and autologous or implant-based approaches. Decisions surrounding postmastectomy breast reconstruction are influenced by factors such as age, cultural beliefs, recovery priorities, and access to care. Although autologous reconstruction often results in higher long-term satisfaction, disparities exist with minority patients more likely to receive this approach, potentially due to systemic or cultural factors. Current tools like BREAST-Q assess satisfaction but fail to capture the complex motivations behind reconstruction decisions. Understanding these influences is critical for improving shared decision-making and tailoring care to enhance quality of life.

Materials and Methods

A questionnaire was developed to assess motivation and patient satisfaction among those choosing autologous, implant-based, or no reconstruction. Retrospective chart reviews identified eligible patients (females aged 18+ with stage 0–III breast cancer, undergoing mastectomy with or without reconstruction between July 1, 2015 and May 1, 2022). Exclusion criteria included stage IV disease, prior bilateral breast surgery, or prophylactic mastectomy. English or Spanish speaking patients were contacted to complete a telephone questionnaire assessing satisfaction, decision-making, regret, and motivations. To validate the survey, initial respondents were re-contacted after 3 weeks to repeat the questionnaire.

Results

Twenty-three female patients participated in the validation study, with a mean age of 56.4 years. Among them, 56.5% reported a family history of breast or ovarian cancer. Regarding the initial surgical procedure, 39.1% underwent simple mastectomy, 30.4% had a nipple-sparing mastectomy, and 30.4% had a skin-sparing mastectomy. For the retest phase, responses were obtained from 20 patients, 70% (14 individuals) of whom had undergone reconstruction. Test-retest reliability analysis showed a percentage agreement of 88.51%, with a Cohen k of 0.435.

Conclusion

This study validates a novel questionnaire aimed at understanding factors influencing postmastectomy breast reconstruction decisions and postoperative satisfaction. Further implementation of this measure will allow for research that will highlight the importance of patient-centered care, shared decision-making, and help address disparities to optimize breast-related quality of life for mastectomy patients.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Predictors of response have a significant effect on clinical decision-making because they may help oncologists select the best treatment for specific patients.
Delaying treatment with ruxolitinib by more than a year leads to decreased response rates and overall survival in patients with myelofibrosis.
A third of patients had a response [to lifileucel], and of the patients who have a response, half of them were alive at the 4-year follow-up.